Viewing Study NCT01331993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-06-15 @ 8:02 PM
Study NCT ID: NCT01331993
Status: COMPLETED
Last Update Posted: 2011-10-18
First Post: 2011-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Bioequivalence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None crossover View
None bioequivalence View
None naproxen View
None esomeprazole View
None vimovo View
None healthy volunteers View